Determination of Health Concepts in β-Propeller Protein–Associated Neurodegeneration
Emma Kotes(Children's Hospital of Philadelphia), Laura Adang(Children's Hospital of Philadelphia), Nivedita Thakur(Montreal Children's Hospital), Vanessa Smith(Ghent University Hospital), Anjana Sevagamoorthy(Children's Hospital of Philadelphia), Sarah Woidill(Children's Hospital of Philadelphia), Francesco Gavazzi(Children's Hospital of Philadelphia), Samuel R. Pierce(Children's Hospital of Philadelphia), Joseph Vithayathil, Eric Yang(Children's Hospital of Philadelphia), Kristy Pucci(Children's Hospital of Philadelphia), Holly Dubbs
Cited by 6
Related Papers
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Janus Kinase Inhibition in the Aicardi–Goutières Syndrome
|New England Journal of Medicine|2020|201
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
|Epilepsia|2018|153